Cross Cat Co (2307) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
21 Jul, 2026Executive summary
Net sales rose 10.1% year-over-year to ¥12,135 million for the nine months ended December 31, 2024, driven by strong performance in financial services and public sector sales, despite a decline in the credit sector.
Operating profit increased 24.6% year-over-year to ¥1,415 million, and ordinary profit rose 23.4% to ¥1,458 million, reflecting higher revenues from core businesses.
Profit attributable to owners of parent declined 1.4% year-over-year to ¥961 million, mainly due to a one-time gain on sale of investment securities in the prior year.
Financial highlights
Gross profit for the nine months was ¥2,958 million, up from ¥2,663 million year-over-year.
Comprehensive income increased 16.4% year-over-year to ¥1,175 million.
Basic earnings per share were ¥67.98, compared to ¥66.90 in the prior year.
Outlook and guidance
Full-year forecast remains unchanged: net sales of ¥15,600 million (+4.5% year-over-year), operating profit of ¥1,580 million (+3.8%), ordinary profit of ¥1,630 million (+3.8%), and profit attributable to owners of parent of ¥1,040 million (–20.7%).
Basic earnings per share for the full year are projected at ¥73.01.
Latest events from Cross Cat Co
- Double-digit profit growth and higher dividends forecast for the fiscal year.2307
Q1 20275 Aug 2026 - Record-high first-half results and double-digit sales growth, with robust sector performance.2307
Q2 202522 Jul 2026 - Record-high revenue and profit for the fourth year, with further growth and returns forecast.2307
Q4 202522 Jul 2026 - Profits and sales rose, driven by financial and public sector growth, with a strong outlook.2307
Q2 202622 Jul 2026 - Record-high revenue and profits for the fifth consecutive year, driven by SI and DX growth.2307
Q4 202622 Jul 2026 - Strong sales and profit growth, higher equity ratio, and treasury share actions marked the quarter.2307
Q1 202522 Jul 2026 - Profits and margins improved on higher sales and asset gains, with a strong equity ratio and positive outlook.2307
Q1 202621 Jul 2026 - Profits and sales rose, with strong DX growth and improved equity ratio; outlook remains positive.2307
Q3 202621 Jul 2026